CNBC - Health
Biotech takeover target Abivax sinks 37% as cancer cases cloud trial data for bowel disease drug
59 minutes ago
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial6 hours ago
Why Trump reversed course to fast-track psychedelic drugs for mental healthcare2 days ago
Replimune to resubmit twice rejected drug for approval after FDA shakeup2 days ago
Oura is launching its smallest smart ring yet, shrinking wearable design by 40%5 days ago
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans5 days ago
Amazon's top health exec is stepping down, will be replaced by Amwell co-founder5 days ago
Trump officials hit California with Medicaid funding freeze5 days ago
Healthy Returns: Eli Lilly makes a new push into vaccines — here's what to know5 days ago
Signos grows foothold in weight-loss wave fueled by GLP-1s with AI tracking5 days ago
How one medical supply CEO is navigating the oil price shock6 days ago
Eli Lilly says next-generation weight loss drug clears crucial obesity trial12 days ago
Cavs owner Dan Gilbert turns grief over son's rare disease into search for cure12 days ago
Eli Lilly accuses church bishops, businessmen of fraud in drug rebate scheme12 days ago
Trump says he's 'concerned' about Ebola after American tests positive in Africa14 days ago
White House adds generic drugs to direct-to-consumer TrumpRx site14 days ago
CDC says American tests positive for Ebola in Africa, risk in U.S. remains low14 days ago
FDA shuffles top drug, biologics leaders in latest leadership shakeup17 days ago
Bristol Myers Squibb turns to China to develop new drugs17 days ago
CDC says there are no U.S. hantavirus cases currently, 41 people being monitored18 days ago
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data18 days ago
Hantavirus isn't another Covid, but experts say it's testing U.S. readiness18 days ago
Trump says Makary resigns as FDA commissioner following backlash19 days ago
Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients20 days ago
Jim Cramer says today's market is punishing stocks harder than 199921 days ago
Hantavirus cases spark brief surge in pharma and biotech stocks — here's why trading is so volatile21 days ago
Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk22 days ago
Fitness wearable Whoop to offer on-demand clinician access to U.S. users25 days ago
Healthy Returns: Novo Nordisk faces Ozempic generics in Canada25 days ago
Planet Fitness stock plunges 30% after company slashes guidance25 days ago
Family office deal-making rebounds in April with healthcare bets26 days ago
Rare disease families find roadmap to drug development at bootcamps26 days ago
